Epizyme - Precio De Mercado

EPZM

11.79

Cambio Diario:

0.81%

Anual:

-54.68%

Precio Día Año
Eisai 7,649.00 -31.00 -0.40% -8.41%
Daiichi Sankyo 3,712.00 47.00 1.28% -49.44%
Abbott 112.88 1.61 1.45% 25.80%
Agios Pharmaceuticals 46.90 1.35 2.96% -12.83%
Amgen 248.07 2.67 1.09% 4.41%
Amarin 6.34 0.27 4.45% -69.91%
Avrobio Inc 14.39 -0.55 -3.68% -30.78%
Biogen 277.51 1.86 0.67% -3.37%
Bluebird Bio 49.69 -0.84 -1.66% -48.14%
Cerulean Pharma 1.44 0 0% -13.25%
Epizyme 11.79 0.10 0.81% -54.68%
Exelixis 23.79 0.08 0.32% 20.39%
Gilead Sciences 67.07 3.75 5.92% 7.09%
GlaxoSmithKline 1,410.40 10.40 0.74% -23.26%
Glaxosmithkline 38.46 -0.01 -0.03% -19.03%
Ionis Pharmaceuticals 61.66 0.38 0.62% 2.72%
Karyopharm Therapeutics 15.03 0.10 0.67% -14.31%
MacroGenics 22.22 1.63 7.92% 83.48%
Merck & Co 83.15 -0.22 -0.26% -7.58%
Mirati Therapeutics 215.67 1.20 0.56% 131.83%
Novartis 85.52 0.49 0.58% -7.77%
Novartis 96.60 0.97 1.01% 1.48%
Pfizer 36.73 0.04 0.11% -8.95%
Regeneron Pharmaceuticals 533.17 15.61 3.01% 46.59%
Seattle Genetics 188.91 3.35 1.80% 73.84%
Spectrum Pharmaceuticals 3.94 0.36 10.03% 29.18%
Vertex Pharmaceuticals 232.08 6.65 2.95% -0.82%
Xencor 49.66 1.20 2.48% 33.75%

Precio Día Año
NASDAQ 13178 179.66 1.38% 40.63%
Russell 2000 2150 26.83 1.26% 27.53%

EPZM:US
El Costo De Ventas
Activos Circulantes
EBIT
Empleados
Eps Ganancias Por Acción
Beneficio Bruto En Ventas
Los Gastos Financieros De La Deuda
Capital De Préstamo
Capitalización De Mercado
Lngresos Netos
Los Gastos De Explotación
Beneficio Operativo
Gastos De Venta Y Administración
Acreedores Comerciales
Deudores Comerciales